Howe D J, Hopkins J A, Johnson S A, Phillips M J
Department of Haematological Medicine, Taunton and Somerset Hospital, Somerset, UK.
Clin Lab Haematol. 1993;15(2):113-8. doi: 10.1111/j.1365-2257.1993.tb00134.x.
Cells obtained from the blood or bone marrow of patients with haematological malignancies can both be stained with fluorescent labelled monoclonal antibodies to determine an immunophenotype and permeabilized with 30% ethanol then stained with propidium iodide for simultaneous DNA analysis. In the technique described here, no evidence of selective depletion of the malignant cell population was demonstrated and decreases in the mean fluorescence intensity of the surface markers were insufficient to affect the sensitivity of flow cytometric analysis. The combined method is simple and robust enough to allow incorporation of DNA analysis into routine immunophenotyping of leukaemia and lymphoma cells.
从血液系统恶性肿瘤患者的血液或骨髓中获取的细胞,既可用荧光标记的单克隆抗体进行染色以确定免疫表型,也可用30%乙醇进行通透处理,然后用碘化丙啶染色以同时进行DNA分析。在此描述的技术中,未显示出恶性细胞群体有选择性耗竭的证据,且表面标志物平均荧光强度的降低不足以影响流式细胞术分析的灵敏度。该联合方法简单且稳健,足以将DNA分析纳入白血病和淋巴瘤细胞的常规免疫表型分析中。